Shire takeover 'would be biggest in pharma industry in 2012'
A Shire takeover would be the biggest deal in the pharma industry in 2012, with Teva one possible buyer.
A takeover of Shire would be the biggest deal in the pharmaceutical industry during a year expected to be dominated by small-scale acquisitions.
According to Reuters, the Anglo-American firm is the subject of takeover speculation, with Teva - which has experience in using negotiation techniques to secure acquisitions - one potential buyer.
Teva is the largest manufacturer of generic drugs in the world and analysts believe it would have support of shareholders to invest in Shire, which began as a specialist in developing treatments for deficit and hyperactivity disorder.
A bid close to $30 billion (£19 billion) is likely to be necessary to secure the takeover and Reuters noted price "could be a sticking point".
One source suggested Teva could wait for Shire's share price to fall as a result of a setback before making a bid, a tactic that has been used in other pharmaceutical acquisitions, such as Roche's purchase of Illumina.
Shire's shares were priced at £23.04 on the FTSE 100 as of 09:00 GMT today (February 15th).
Posted by Ken Hayes
Source: Reuters, February 15th